
Rau And Co Pharma Private Limited
Pharmaceutical trading company based in Chennai, Tamil Nadu.
Pharmaceutical trading company based in Chennai, Tamil Nadu.
Rau And Co Pharma Private Limited (RACPPL) is a Private Limited Indian Non-Government Company incorporated in India on 18 February 2016 (Nine years 14 days old ). Its registered office is in Tiruvallur, Tamil Nadu, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 1.00 M.
The company currently has active open charges totaling ₹35.00 Cr. The company has closed loans amounting to ₹21.88 Cr, as per Ministry of Corporate Affairs (MCA) records.
Srinivasa Manickam, Sanjeevi Gurugopi, and Varun Mehta serve as directors at the Company.
Tiruvallur, Tamil Nadu, India
+91-XXXXXXXXXX
-
U51109TN2016PTC104216
104216
Private Limited Indian Non-Government Company
18 Feb 2016
28 Sep 2024
31 Mar 2024
Unlisted
Roc Chennai
Name | Designation | Appointment Date | Status |
---|---|---|---|
Srinivasa Manickam ![]() | Director | 27-Feb-2023 | Current |
Sanjeevi Gurugopi ![]() | Director | 21-Oct-2021 | Current |
Varun Mehta | Director | 10-Jul-2024 | Current |
Rau And Co Pharma Private Limited, for the financial year ended 2022, experienced modest growth in revenue, with a 4.97% increase. The company also saw a substantial improvement in profitability, with a 64.58% increase in profit. The company's net worth observed a substantial decline by a decrease of 20.66%.
Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
---|---|---|---|---|---|---|---|
Total Revenue |
| ||||||
Revenue from Operations |
| ||||||
Total Assets |
| ||||||
Profit or Loss |
| ||||||
Net Worth |
| ||||||
EBITDA |
|
In 2020, Rau And Co Pharma had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Srinivasa Manickam and Varun Mehta are mutual person
Srinivasa Manickam and Varun Mehta are mutual person
Srinivasa Manickam and Varun Mehta are mutual person
₹350.00 M
₹218.80 M
Date | Lender | Amount | Status |
---|---|---|---|
21 Oct 2019 | Axis Bank Limited | ₹35.00 Cr | Open |
07 Dec 2017 | Others | ₹10.38 Cr | Satisfied |
11 Jul 2017 | Hdfc Bank Limited | ₹6.50 Cr | Satisfied |
05 Jul 2016 | The Hongkong And Shanghai Banking Corporation Limited | ₹5.00 Cr | Satisfied |
Rau And Co Pharma has a workforce of 26 employees as of Apr 08, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Rau And Co Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Rau And Co Pharma's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Rau And Co Pharma Private Limited last Annual general meeting of members was held on 28 Sep 2024 as per latest MCA records.
Varun Harikishan Mehta was appointed as a Director was appointed as a Director on 10 Jul 2024 & has been associated with this company since 7 months 24 days .
Rau And Co Pharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Chennai.
Srinivasa Ramanathan Manickam was appointed as a Director was appointed as a Director on 27 Feb 2023 & has been associated with this company since 2 years 5 days .
Sanjeevi Gurugopi was appointed as a Director was appointed as a Director on 21 Oct 2021 & has been associated with this company since 3 years 4 months .
A charge with Axis Bank Limited amounted to Rs. 350.00 M with Charge ID 100298100 was registered on 21 Oct 2019.
Rau And Co Pharma Private Limited was incorporated on 18 Feb 2016.
The authorized share capital of Rau And Co Pharma Private Limited is ₹ 1.00 M and paid-up capital is ₹ 1.00 M.
Currently 3 directors are associated with Rau And Co Pharma Private Limited.
As per Ministry of Corporate Affairs (Mca), the registered address of Rau And Co Pharma Private Limited is Old Door No. 26 Ground Floor 1St Street Ambattur Industrial Estate North Pattar Avakkam, India, Chennai, Tamil Nadu, 600098.
The corporate identification number (CIN) of Rau And Co Pharma Private Limited is U51109TN2016PTC104216 and the company number is 104216 as per Ministry of Corporate Affairs (MCA).
According to the financial reports for the fiscal year 2022, the revenue trend for Rau And Co Pharma Private Limited has risen by 4.97%.
As Per 2022 financial reports, 26 employees are currently employed by Rau And Co Pharma Private Limited.
The financial reports for the fiscal year 2022 indicates that The net worth of Rau And Co Pharma Private Limited has experienced an downturn of -20.66%.
As per the financial statements for fiscal Year 2022, The total open charges for Rau And Co Pharma Private Limited amount to ₹ 35.00 Cr.
The most recent Balance Sheet for Rau And Co Pharma Private Limited was filed with the ROC on 31 Mar 2024.
EG
KM
MS
MG
BG
SV
SG